Vivo Opportunity LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Purchase |
2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Vivo Opportunity LLC | 2,482,727 4.500% |
801,528 (+47.68%) |
Filing |
| 2023-02-13 5:40 pm Purchase |
2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Vivo Opportunity LLC | 1,681,199 6.800% |
681,199 (+68.12%) |
Filing |
| 2022-09-08 4:00 pm Purchase |
2022-08-31 | 13G | Astria Therapeutics, Inc. ATXS |
Vivo Opportunity LLC | 1,000,000 7.100% |
1,000,000 (New Position) |
Filing |